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1. Introduction
  Chikungunya is one of the major arboviral infections in tropical 
countries and it is transmitted mainly by Aedes aegypti and Aedes 
albopictus mosquitoes. Chikungunya virus (CHIKV) belongs to 
the Semliki Forest antigenic complex of the genus Alphavirus, 
family Togaviridae[1] and caused a number of explosive and 
unpredictable epidemics in Africa, South Asia and Americas[2,3]. 
The re-emergence as a virulent pathogen interspersed by periods of 
disappearance that lasts several years to a few decades has become 
a major global health concern[4]. Increasing prevalence of CHIKV 
infection currently results in a wide range of atypical clinical 
manifestations involving neurological, cardiovascular, skin, ocular, 
and renal systems and persistent debilitating rheumatological 
symptoms that may last for years, invariably affecting all age groups 
of both genders[5,6]. Clinical symptoms of CHIKV infection are 
similar to that of other alphaviruses such as dengue virus, Sindbis 
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virus, West Nile virus and Ross River virus, with arthralgia being the 
hallmark feature[7]. 
  CHIKV infected patients are treated symptomatically, with 
administration of nonsteroidal anti-inflammatory drugs or 
corticosteroids to control arthralgia and myalgia[8] as there is no 
specific antiviral drug or vaccine available for treating this infection. 
The level of viremia correlates with the severity of disease with 
high viremia often seen in arboviral diseases including CHIKV. 
Hence, antivirals that can reduce the level of viremia or the viremic 
phase could possibly reduce the severity of the viral diseases. The 
drugs used to treat the disease on the basis of symptoms are not 
only expensive but also exhibit toxicity or adverse effects, and are 
not helpful in reducing the viral loads effectively[9,10]. A double-
blind, randomized clinical trial was conducted to evaluate the 
efficacy of chloroquine in acute CHIKV viremia, but the study did 
not show any benefits in terms of the duration of viremia or the 
severity and duration of clinical symptoms[11]. Reports on synthetic 
broad-spectrum alphavirus inhibitors targeting cellular enzymes are 
available; however, these compounds are limited by their narrow 
therapeutic index or immunomodulatory effects that are considered 
unfavorable for the treatment of clinical infection[12-14]. Arbidol, 
a broad spectrum synthetic antiviral drug was reported to have 
effective CHIKV inhibitory activity by blocking the viral replication 
cycle at an early stage ie., during virus attachment or at viral entry; 
however, the origin of ARB resistant mutant strains limited its 
useness against the virus[9,15]. Presently, none of the antiviral drugs 
have been approved for treating CHIKV infection.
  It has been found that the natural products such as plant extracts 
and plant derived compounds (phytochemicals) can be used as 
potential sources for the development of effective and novel 
antiarboviral drugs as they do not cause adverse effects and many are 
less toxic or non toxic[10]. The antiviral mechanism of these agents 
is validated on the basis of their antioxidant and anti-inflammatory 
activities, scavenging capacities, immune-stimulatory properties 
inhibiting viral DNA and RNA synthesis, inhibition of viral entry 
etc[16]. Though reports on antiviral activities of plant extracts and/
or phytochemicals against arboviruses such as dengue are available, 
studies on anti-CHIKV activities of phytochemicals are limited[10,17-
19]. 
  The medicinal plant Cynodon dactylon (L.) (C. dactylon) Pers. 
belongs to the family Poaceae, commonly named as Bermuda 
grass, and has been known to exhibit antimicrobial, antiviral, 
antioxidant, antidiabetic, hypolipidemic and hepatoprotective effects 
and much of the medicinal properties are attributed to glycosides, 
polysaccharides, flavonoids, terpenes, alkaloids, phenolics, amino 
acids, and phytosterols[20,21]. This plant has been used in the 
traditional medicine for treating various ailments such as calcus, 
snake bites, hypertenstion, epilepsy, syphilis, wound infection, piles, 
dropsy, and convulsions. The extracts of the plant were reported to 
show antiviral activity against white spot syndrome virus of shrimp 
both in vitro and in vivo[22] and porcine reproductive and respiratory 
syndrome virus[23]. However, reports on the therapeutic potential 
of the plant against human viruses are scarce and there is no report 
on anti-arboviral activity from the constituents of the plant so far. 
Hence, in this study, an attempt has been made to use luteolin and 
apigenin rich fraction from the ethanolic extract of C. dactylon for its 
protective efficacy against CHIKV in vitro.
2. Materials and methods 
2.1. Chemicals and reagents
  Cell culture reagents and fetal bovine serum (FBS) were purchased 
from Gibco BRL (Gaithersburg, MD, USA). Culture medium, 
dimethyl sulfoxide (DMSO), penicillin G, streptomycin, fungizone, 
diethyl pyrocarbonate, luteolin and apigenin (HPLC purified) 
were purchased from Sigma Aldrich (St. Louis, USA). 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) 
was purchased from Hi Media, India. HPLC grade solvents (Fisher 
Scientific, India) were used for the phytochemical extraction and 
HPLC analysis.
2.2. Plant material and isolation of active fractions having 
anti-CHIKV components 
  The whole plant of C. dactylon was collected during December, 
2012 in the Western Ghats region around Madurai District of 
Tamilnadu, India. The plant sample was authenticated by Botanical 
Survey of India, Coimbatore and the voucher specimen (No.BSI/
SRC/2/23/2013-14.TECH.471) was deposited in Botanical Survey 
of India, Coimbatore, Tamilnadu.
2.3. Preparation of solvent extract
  The fresh plant C. dactylon was washed, air dried in shade at 
ambient temperature and the dried material was made to a fine 
powder (1 200 g; particle size ~0.25 mm) using a laboratory mill and 
defatted with 1 000 mL petroleum ether (60-80 ℃) for 3 to 4 h in 
a Soxhlet apparatus. The resulting residue was dried and extracted 
further with 95% ethanol. The ethanolic extract was filtered using 
Whatman No.1 filter paper and concentrated on a rotary evaporator 
at 40-50 ℃ under reduced pressure. The powder is dissolved in 0.2% 
DMSO and stored at -20 ℃ until further use.
2.4. Isolation of active fraction from C. dactylon
  The ethanolic extract was chromatographed on silica gel column (3 
cm伊50 cm) eluted with ethanol/water (90:10, v/v) to obtain fractions 
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based on the absorbance at 210 nm using UV-Vis spectrophotometer. 
The fractions were reconstituted, concentrated and checked for 
in vitro anti-CHIKV activity. The fraction showing anti-CHIKV 
activity (F4) was further subjected to Reverse Phase-HPLC analysis 
(ABL1525, UK) with a Phenomenex Hypersil C18 reversed phase 
column (5 毺m; 4.6 mm伊250 mm) using ethanol-acetonitrile-acetic 
acid-phosphoric acid-H2O (100:50:10:10:100, v/v) as a mobile phase 
at a flow rate of 1.0 mL/min. The injector was a Rheodyne model 
valve with 20 毺L loop. The absorbance of eluent was detected at 
200-400 nm using photodiode array detector. The phytochemicals 
in the active fraction such as luteolin and apigenin were detected by 
retention time (RT) with respective to their standards. To prepare 
standard stock solutions, 50 mg each of luteolin and apigenin 
weighed and transferred separately into a 50 mL volumetric flask, 
dissolved in 50 mL of ethanol and sonicated for 5 min to produce 1 
mg/mL stock solution.  
2.5. Identification of active compounds by GC-MS
  Ethanolic fraction of C. dactylon was analysed by GC-MS (JEOL 
GCMATE-栻) equipped with VF-5 MS capillary column (30 m伊
0.25 mm i.d., 0.25 毺m); helium was used as a carrier gas at a flow 
rate of 1 mL/min. The samples were injected with a split ratio of 
1:10. Injector and detector temperatures were 80 ℃ (for 2 min) and 
275 ℃, respectively. Mass spectra were recorded over 40-400 amu 
range in multiple ion detection mode with 70 eV of ionization energy 
and ion source temperature of 240 ℃. Mass spectra were acquired in 
positive ion mode. Identification of components of C. dactylon was 
performed by matching the obtained mass spectra data with NIST 
MS search version on Wiley-8 and FAME library.
2.6. Cell propagation and scoring of viral titers
  The Vero cells were obtained from National Centre for Cell 
Science, Pune, India and sub-cultured in Dulbecco’s Modified 
Eagle’s Medium supplemented with 10% FBS, 100 毺g/mL 
penicillin G, 100 毺g/mL streptomycin and 100 毺g/mL fungizone. 
The cultures were maintained at 37 ℃ in a humidified 5% CO2 
atmosphere. CHIKV culture was obtained from National Institute 
of Virology, India, activated with 10 毺g/mL trypsin for 60 min at 
37 ℃ and propagated in Vero cells cultured in a 96-well microplate. 
After 72 h, the viral titers were scored for cytopathic effect (CPE) 
and the results were expressed as 50% tissue culture infectious dose 
(TCID50)  per mL.
2.7. Cytotoxicity studies
  Cytotoxicity of the ethanolic fraction of C. dactylon was determined 
by MTT reduction assay[24]. Briefly, monolayer of Vero cells (at 
a density of 2伊104 cells/well) seeded in 96-well microplates was 
treated with different concentrations of ethanolic fraction ranging 
from 5 to 500 毺g/mL (5, 10, 25, 50, 75, 100, 150, 200, 250, 300, 
400 and 500 毺g/mL) for 72 h. Both solvent (0.2% DMSO) and cell 
controls were included in the study. Then 20 毺L of MTT solution 
(1 mg/mL) was added to each well. The plates were incubated at 
37 ℃ for 3 h followed by the addition of 0.2% DMSO to each well. 
The absorbance of each well was measured at 620 nm using 96-
well microplate reader (Thermo Multikan EX, USA). The cytotoxic 
concentration (CC50) was determined for the fraction.
2.8. Antiviral activity studies
  Antiviral activity was assessed by the ability of the ethanolic 
fraction to inhibit the CPE of CHIKV on the treated Vero cell 
monolayers cultivated in 96-well microplates. Briefly, the cells (2
伊104 cells/well) were seeded onto 96-well microplates and grown 
to confluence. Then, the culture medium was removed in all wells 
followed by the addition of 200 毺L of the activated CHIKV 
inoculum (TCID50 = 2.81伊10
-5/mL; 1.94×伊105 PFU/mL) to infect 
cells for 2 h at 37 ℃ in 5% CO2 atmosphere. Subsequently, the 
infected cells were treated with the non-toxic concentrations ranging 
from 5 to 200 毺g/mL (5, 10, 25, 50, 75, 100, 150 and 200 毺g/mL) 
of fraction in fresh medium with 2% of fetal calf serum. After 72 h 
incubation period, the viability of viral infected cells was studied by 
MTT assay as described earlier along with cell and virus controls.  
2.9. RNA isolation and RT-PCR analysis
  The viral infected and noninfected cells were washed with 1× PBS 
thrice, treated with trypsin and centrifuged at 10 000 rpm for 5 
min to remove dead cells and debris. Total RNA was extracted by 
using QIA amp Viral RNA Mini Kit (Qiagen, USA) according to 
manufacturer’s instructions and the extracted RNA was dissolved 
in 1% DEPC treated water. The amount of RNA was determined 
by measuring absorbance at 260 nm. cDNA was synthesized 
and amplified by using CHIKV E2 gene specific primers: F 
5’TATCCTGACCACCCAACGCTCC-3’ (Genome position: 9403-
9424) and R 5’ ACATGCACATCCCACCTGCC-3’ (Genome 
position: 9693-9712)[25] from total RNA in an RNase free condition. 
PCR-amplified products were resolved on 1.5% agarose gels 
containing ethidium bromide (0.2 毺g/mL) and visualized under UV 
light. The housekeeping gene 毬-actin served as reference control.
2.10. Statistical analysis
  All in vitro experiments were carried out in eight well replicates and 
the experiments were repeated thrice. The results were statistically 
analyzed by SPSS software 17.0 package and the values were 
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presented as Mean ± SD. The level of P<0.05 was considered to be 
statistically significant. 
3. Results 
3.1. Preparation of anti-CHIKV active ethanolic fraction 
  The yield of defatted ethanolic extract from C. dactylon was 
about 48 g which upon re-suspension in distilled water followed 
by filtration and concentration using vacuum evaporator yielded 
15.26 g. The concentrated extract was analysed for the presence of 
phytochemicals such as alkaloids, flavonoids, saponins, tannins, 
sterols, glycosides and carbohydrates, and the biochemical analysis 
showed the presence of alkaloids, flavonoids and glycosides (data 
not shown). The concentrated powder (5 g dissolved in DMSO) 
was subjected to silica gel chromatography for obtaining five 
different fractions (fractions F1 to F5; Figure 1). The fractions 
were reconstituted, lyophilized, dissolved in DMSO and evaluated 
for anti-CHIKV activity at the concentration of 50 毺g/mL using 
Vero cell lines (data not shown). Only a single fraction (F4) showed 
anti-CHIKV activity and this fraction was further evaluated for its 
cytotoxicity and antiviral studies. 
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Figure 1. Separation of fractions from ethanolic extract of C. dactylon by 
silica gel chromatography. 
3.2. HPLC and GC MS studies on identification of 
phytochemicals in ethanolic fraction
  The partitioned ethanolic fraction (F4) of C. dactylon that exhibited 
antiviral activity was analyzed by RP-HPLC after separation of 
various active components by increasing the polarity of the solvents 
(Figure 2). Though the HPLC chromatogram of anti-CHIKV 
active fraction was found to contain several well resolved peaks 
with distinct RT, two prominent peaks corresponding to the RT of 
about 20 min and 24 min were observed at 270 nm (Figure 2a). 
The phytochemicals standards for flavonoids such as luteolin and 
apigenin of C. dactylon were procured and resolved by HPLC using 
the same conditions adopted for the fraction sample (Figure 2b and 
2c). The results showed that the RT of the luteolin and apigenin 
standards matched with that of the RT of components in the fraction 
indicating the presence of the two predominant phytochemicals 
in the anti-CHIKV active fraction. GC-MS spectrum revealed the 
presence of three prominent peaks having the molecular weight 
of 207, 267 and 281 of which the peaks corresponds to 267 and 
281 matched with the molecular weight of apigenin (MW 270.24) 
and luteolin (MW 286.2) (Figure 3). Hence, the presence of these 
phytochemicals as major constituents in the anti-CHIKV active 
fraction was confirmed. Other peaks having the molecular weight 
~207 and ~295 were identified to be hexamethyl cyclotrisiloxane 
(MW 222) and phytol (MW 296) respectively from the ethanolic 
fraction (F4) of C. dactylon. 
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Figure 2. RP-HPLC resolution of (a) luteolin and apigenin in the anti-
CHIKV ethanolic fraction of C. dactylon; (b) luteolin and (c) apigenin 
standards.
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Figure 3. GC-MS analysis of anti-CHIKV active ethanolic fraction of 
C. dactylon.  
3.3. Cytotoxicity studies
  The studies on cytotoxicity of ethanolic fraction at the concentration 
of 5-500 毺g/mL in Vero cell line showed that the fraction treated 
cell lines developed confluence upto 250 毺g/mL concentration 
Krishnan Saravana Murali et al./Asian Pacific Journal of Tropical Medicine (2015)352-358356
at 48 h as comparable to that of controls (untreated and DMSO 
treated cells). However, cells treated with >250 毺g/mL of ethanolic 
fraction exhibited toxicity as observed by microscopic analysis, ie., 
changes in morphology of cells, loss of monolayer, granulation and 
vacuolization in the cytoplasm, and cell damage when compared to 
untreated as well as cells treated with <250 毺g/mL concentration 
(Figure 4). Hence, the ethanolic fraction up to 250 毺g/mL (CC50) 
could be used to test the antiviral activity without affecting much of 
the cell viability (Figure 5).
 
Figure 4. Cytotoxicity studies on Vero cells treated with various 
concentration of anti-CHIKV fraction.
(A) Control; (B) 25 毺g/mL; (C) 50 毺g/mL; (D) 75 毺g/mL; (E) 100 毺g/
mL; (F) 150 毺g/mL; (G) 200 毺g/mL and (H) 250 毺g/mL.
 
Figure 5. Antiviral activity of ethanolic fraction of C. dactylon on Vero cells. 
(A) Virus control showing CPE; (B) Cells treated with 10 毺g/mL of fraction; 
(C) 25 毺g/mL of fraction and (D) 50 毺g/mL of fraction. 
3.4. Antiviral activity by MTT assay and RT-PCR
  Antiviral activity of the ethanolic fraction against CHIKV was 
determined by CPE reduction and MTT assay after treating the viral 
infected Vero cells with the non toxic concentration (5 to 200 毺g/
mL) for 72 h (Figure 6). Results revealed that the untreated infected 
control cells showed maximum CPE; among the concentrations 
tested, the fraction at the concentration of 10, 25 and 50 毺g/
mL exhibited significant antiviral activity ie. 68%, 88% and 98% 
respectively as observed by the reduction or nil CPE whereas 
the fraction at the concentration of 5 毺g/mL showed minimum 
inhibitory effect (36%) as observed by the low degree of CPE 
(Figure 5 and 6). 
  The cells treated with various concentrations of the fraction 
were subjected to RT-PCR and the amplified gene products (E2) 
were resolved in 1.5% agarose gel. The presence of bands in the 
cells treated with fractions at the concentrations of 5 毺g/mL and 
10 毺g/mL indicated that the concentration was too low to arrest the 
viral replication completely, whereas the concentrations 25 毺g/mL 
remarkably exhibited antiviral activity as shown by the absence of 
bands in the gel (Figure 7a; i-v). The expression of house keeping 
gene 毬-actin (reference control) was observed in all wells including 
the controls and fraction treated infected cells (Figure 7b; i-vi). 
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Figure 6. Cytotoxicity and antiviral effect of the anti-CHIKV active ethanolic 
fraction from C. dactylon.
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Figure 7. Studies on anti-CHIKV activity using ethanolic fraction from C. 
dactylon by RT-PCR.
(a) Expression of E2 viral gene (305 bp) from infected cells treated with 
fraction at the concentration of (i) 5 毺g/mL, (ii) 10 毺g/mL, (iii) 25 毺g/mL, 
(iv) viral uninfected cells (negative control) and (v) expression of E2 gene 
(virus control); 
(b) Expression of 毬-actin (540 bp) in viral infected cell lines treated with 
fraction at the concentration of (i) 5 毺g/mL, (ii) 10 毺g/mL, (iii) 25 毺g/mL, 
(iv) 50 毺g/mL, (v) negative control and (vi) virus control.     
4. Discussion
  Synthetic anti-CHIKV drugs such as chloroquine, ribavirin and 
arbidol did not show any significant therapeutic effects in clinical 
cases[14]. Hence, there is a necessity to explore the possibility of 
searching antiviral phytoconstituents with high efficiency, low 
toxicity and high viral inhibititory activity. In the present study, an 
attempt was made to study the anti-CHIKV activity of fractions 
from ethanolic extract of C. dactylon as the plant is known to exhibit 
several medicinal properties including antiviral activity and these 
properties are attributed to various phytochemicals[20-23]. 
  Though the crude ethanolic extract of C. dactylon contained 
alkaloids, flavonoids and glycosides, the anti-CHIKV activity using 
Vero cell lines was exhibited by the flavonoid rich ethanolic fraction 
(F4) separated by silica gel chromatography. Further analysis by 
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RP-HPLC and GC-MS revealed the presence of flavonoids such 
as luteolin and apigenin as predominant phytoconstituents in the 
ethanolic fraction. Hence, the anti-CHIKV activity of C. dactylon 
could be mainly due to the luteolin and apigenin flavonoids in the 
ethanolic fraction. Flavonoids are widely distributed in edible plants 
that have been used in traditional medicine, and are likely to have 
minimal toxicity. Antiviral activities of flavonoids such as quercetin, 
fisetin, rutin, glabranine, baicalein and genistein are reported to 
display antiviral properties against some viruses including dengue, 
herpes simplex virus (HSV)-1, HSV-2, human cytomegalo virus 
and some types of human adenoviruses[20,26-29]. They exhibit 
antiviral activity by either preventing the entry of viruses into cells 
or inhibiting the intracellular replication of virus. Flavonoids with 
a 5,7-dihydroxyflavone structure such as apigenin, chrysin, silybin 
and naringenin are reported to inhibit replication of rhinoviruses, 
picornoviruses, CHIKV, HIV and Enterovirus-71[13,30,31]. However, 
there is no report on luteolin or the flavonoids from extracts of
C. dactylon having anti-CHIKV activity.  
  The cytotoxicity studies showed that the ethanolic fraction up to 
250 毺g/mL concentration could be used to test the antiviral activity 
without affecting much of the cell viability. It was reported that 
the ethanol extract of C. dactylon exhibited replicatory inhibitory 
effect against porcine reproductive and respiratory syndrome virus 
propagated in MARC-145 cells at the concentration of 780 毺g/mL
without exhibiting cytotoxicity[23]. It was also reported that the 
ethanolic extract of C. dactylon was found to be safe at the oral dose 
level up to 400 mg/kg using mice and the concentration of extract 
between 100 to 400 mg/kg effectively prevented arthritis through 
reducing inflammation by suppression of inflammatory cells as 
well as secretion of proinflammatory mediators[32]. As arboviruses 
including CHIKV infection share rhematological manifestations 
ie., severe inflammation in joints, the ethanolic fraction of
C. dactylon can be effectively used in reducing the inflammation 
in joints and thereby reducing the severity of the disease. Also, 
it was reported recently that luteolin and luteolin glycosides 
showed anti-inflammatory effect in lipopolysaccharide-stimulated 
macrophages and the phytochemicals were less toxic potential 
alternative to current anti-inflammatory drugs with promising use 
in pharmaceutical and food supplement industries[33]. Hence, the 
antiviral preparation of the present study is important not only in 
terms of exhibiting efficiency in antiviral activities with the presence 
of two predominant flavonoid phytochemicals but also reducing 
the CHIKV associated rheumatological manifestations through 
suppressing the severity of inflammation.
  It was shown that natural compounds with a 5,7-dihydroxyflavone 
structure such as apigenin could inhibit CHIKV replication with 
IC50 value in the range of 22.5 毺M to 126.6 毺M[13]. The study 
reported the antiviral mechanism of the flavonoids having the 
dihydroxyflavone structure and their target site of action against 
CHIKV was replication rather than entry; it was shown that these 
flavonoids inhibited CHIKV replication once they gain entry into the 
host cells but were ineffective in preventing the entry of virus into 
the host cell. It was suggested that six different flavonoids including 
apigenin and luteolin were reported to inhibit the production of 
nucleoprotein by highly pathogenic A avian influenza virus in 
vitro using human lung epithelial (A549) cells without exhibiting 
toxicity[34]. Apigenin-7-O-glucoside and luteolin derived from two 
different plants such as Melissa officinalis and Aspalathus linearis 
were found to inhibit Rota virus infection using in vitro study 
employing MA104 cells at IC50 concentrations of 150 毺M and 
116 毺M respectively[35]. The advantage of the present study is to 
provide a preparation having both apigenin and luteolin flavonoids 
exhibiting potential anti-CHIKV activity; and to our knowledge, 
this is the first report on the use of single plant based preparation 
of fraction rich in two anti-CHIKV flavonoids. Besides, the 
fraction of the current study has potential antiviral effect at minimal 
concentrations ie. 25 to 50 毺g/mL and it did not exhibit cytotoxicity 
even upto the concentration of 250 毺g/mL. However, earlier reports 
on antiviral activities of the plant suggested the use of extracts at 
higher IC50 than the one reported in this study. Besides anti-CHIKV 
activity, the fraction is envisaged to have the prospects of reducing 
the severity of CHIKV associated symptoms as the flavonoids of 
the fraction have anti-inflammatory and anti-arthritic activities. The 
application of the fraction can be potentially extended against other 
arboviruses such as dengue, Japanese encephalitis etc and treating 
the viral diseases through scale up as well as clinical and economical 
validation.            
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